522644-04-8 Usage
Uses
Used in Pharmaceutical Synthesis:
(1R,2S)-2-AMINO-CYCLOOCTANECARBOXYLIC ACID is used as a building block in the synthesis of pharmaceuticals for its unique cyclic structure and chirality. It can contribute to the development of novel drugs with improved efficacy and selectivity.
Used in Organic Chemistry Research:
In the field of organic chemistry, (1R,2S)-2-AMINO-CYCLOOCTANECARBOXYLIC ACID serves as a valuable compound for studying the synthesis and reactions of cyclic amino acids. Its unique structure allows for exploration of new reaction pathways and the development of innovative synthetic methods.
Used in Medicinal Chemistry Research:
(1R,2S)-2-AMINO-CYCLOOCTANECARBOXYLIC ACID is utilized in medicinal chemistry research to investigate its potential as a therapeutic agent or as a structural component in the design of new pharmaceuticals. Its chiral nature and cyclic structure offer opportunities for the discovery of compounds with specific biological activities and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 522644-04-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,2,6,4 and 4 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 522644-04:
(8*5)+(7*2)+(6*2)+(5*6)+(4*4)+(3*4)+(2*0)+(1*4)=128
128 % 10 = 8
So 522644-04-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H17NO2/c10-8-6-4-2-1-3-5-7(8)9(11)12/h7-8H,1-6,10H2,(H,11,12)/t7-,8+/m1/s1
522644-04-8Relevant academic research and scientific papers
Lipase-catalyzed enantioselective ring opening of unactivated alicyclic-fused beta-lactams in an organic solvent.
Forro, Eniko,Fueloep, Ferenc
, p. 1209 - 1212 (2007/10/03)
[reaction: see text] A highly efficient and very simple method was developed for the synthesis of enantiopure beta-amino acids (e.g. cispentacin) and beta-lactams through the enzyme-catalyzed enantioselective ring opening of unactivated alicyclic beta-lac
